InterTabac 2025 Insights|Surge in Nicotine Pouch Brands: Higher Strengths & Category Diversification

Sep.20.2025
InterTabac 2025 Insights|Surge in Nicotine Pouch Brands: Higher Strengths & Category Diversification
At InterTabac 2025, nicotine pouches emerged as one of the biggest highlights. Hall 6 was almost entirely taken over by pouch brands. Based on 2Firsts’ on-site observations, products commonly featured high nicotine strengths starting at 15 mg, with some reaching as high as 150 mg. Beyond nicotine pouches, exhibitors also rolled out caffeine/energy pouches, CBD pouches, and oral dissolvable films, while heavily emphasizing “Made in Sweden” as a market credential. Multiple OEM providers showcased

2Firsts, September 19, 2025, Dortmund, Germany — InterTabac 2025 runs from September 18 to 20. During the show, 2Firsts toured the halls to track new releases and industry moves, bringing first-hand updates and trend insights across the novel-nicotine space.

 

On site, 2Firsts observed an explosive increase in nicotine pouch brands, with Hall 6 effectively serving as a dedicated hub for the category.

 

The hall gathered numerous European brands, particularly from Sweden, Denmark, and Norway, alongside players from the UK and India, underscoring the internationally competitive landscape for nicotine pouches.

 

InterTabac 2025 Insights|Surge in Nicotine Pouch Brands: Higher Strengths & Category Diversification
A variety of packaged products | Image source: 2Firsts

 

A representative from a Belarusian brand told 2Firsts that Russia, Belarus, and neighboring markets demand notably higher nicotine levels than many other regions; their own lines start at 15 mg and go up to 60 mg—a higher baseline compared with ZYN’s 3 mg offerings. Products claiming up to 150 mg nicotine were even spotted at the show.

 

InterTabac 2025 Insights|Surge in Nicotine Pouch Brands: Higher Strengths & Category Diversification
Nicotine pouch with 150mg|Image source: 2Firsts

 

Beyond nicotine pouches, some companies introduced caffeine/energy pouches, CBD oral pouches, and nicotine oral dissolvable films to extend pouch-style portfolios and meet diverse consumer needs. Notably, even brands not from Sweden often highlighted “Swedish manufacturing” in their marketing materials.

 

InterTabac 2025 Insights|Surge in Nicotine Pouch Brands: Higher Strengths & Category Diversification
Promoting Swedish manufacturing | Image source: 2Firsts

 

At the same time, nicotine manufacturers and OEMs were out in force. Some suppliers demonstrated production processes live and offered corresponding ODM brand-customization services.

 

InterTabac 2025 Insights|Surge in Nicotine Pouch Brands: Higher Strengths & Category Diversification
Customization of Nicotine Brands | Image source: 2Firsts

 

Several OEM exhibitors prioritized white-label solutions, offering customized production for nicotine pouches and energy pouches, support for custom-mold tins and label design, with starting prices around €1.00 and lead times as fast as 38 days.

 

InterTabac 2025 Insights|Surge in Nicotine Pouch Brands: Higher Strengths & Category Diversification
Nicotine pouch OEM service | Image source: 2Firsts

 


For more on-the-ground coverage, visit the 2Firsts InterTabac Special Section.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
 $20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
$20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
An Illinois court ordered three companies tied to Posh vapes to pay $20 million and permanently restricted the sale, marketing and distribution in Illinois of products lacking required FDA authorization. The consent order also imposes downstream distributor controls, age-verification measures and social-media marketing limits, creating a new state-level compliance benchmark for disposable vape businesses.
Regulations
Aug.05
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Japan Tobacco (JT) will launch MEVIUS Tropical Option, a new tobacco stick for Ploom, nationwide in Japan from October 6, 2026. The capsule-format product combines mango-oriented sweetness with menthol cooling, adding a tropical flavor to the MEVIUS Ploom tobacco-stick lineup for the first time. Each pack contains 20 sticks and will launch at JPY 590. The product is compatible with all Ploom devices, and its addition will expand the Ploom tobacco-stick portfolio to 32 variants.
Sep.08
Smoore Wins Three Heated Device Supply Lots in China Tobacco Jiangsu’s Overseas Market Project Covering Japan, South Korea and Southeast Asia
Smoore Wins Three Heated Device Supply Lots in China Tobacco Jiangsu’s Overseas Market Project Covering Japan, South Korea and Southeast Asia
China Tobacco Jiangsu Industrial Co., Ltd. (JSIC) has completed its 2026-2028 heated device procurement project, with Shenzhen Smoore Technology Limited securing final supply contracts for three lots: U1, C1 and C2. The project was launched through a public tender in June 2026 to support overseas markets and involved heated tobacco devices carrying JSIC’s “iRod” trademark. Candidate supplier results published on July 13 showed Smoore ranked first for the three awarded lots, while Shenzhen Yunxi Intelligent Technology Co., Ltd. and Shenzhen Bodi Technology Development Co., Ltd. participated in the bidding process.
Aug.03
From Border-Logistics Insiders to Retail Service Stations, Australia Mounts a Sweeping Crackdown on the Illicit Nicotine Trade as iGET Vapes Surface in A$80 Million Crime Networks
From Border-Logistics Insiders to Retail Service Stations, Australia Mounts a Sweeping Crackdown on the Illicit Nicotine Trade as iGET Vapes Surface in A$80 Million Crime Networks
Australian authorities have disclosed two major enforcement actions that go beyond product seizures and retail closures to examine how illicit tobacco and vape networks operate. On Aug. 14, the Multi Agency Strike Team said seven people had been charged and two criminal networks were valued by authorities at a combined A$80 million, or about US$56.8 million. Investigators allege the groups used bonded warehouses, freight businesses and “trusted insiders” in legitimate industries to circumvent border controls. In a separate operation on Aug. 11, more than 100 service stations were targeted as authorities sought information on illicit tobacco importation, distribution networks and the movement of sales proceeds.
Aug.17
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04